Glioma patient-reported outcome assessment in clinical care - Authors' reply

Affiliations

¹ Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20817, USA. Electronic address: terri.armstrong@nih.gov.
² Division of Neuro Oncology, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
³ The Brain Tumour Charity, Farnborough, UK.
⁴ Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
⁵ Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.

Comment

Terri S Armstrong et al. Lancet Oncol. 2020 May.

. 2020 May;21(5):e231.

doi: 10.1016/S1470-2045(20)30241-2.

¹ Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20817, USA. Electronic address: terri.armstrong@nih.gov.
² Division of Neuro Oncology, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
³ The Brain Tumour Charity, Farnborough, UK.
⁴ Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
⁵ Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.

No abstract available

Comment on

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR, Jenkinson D, Kluetz P, Mendoza T, Rubinstein L, Sul J, Weller M, Wen PY, van den Bent MJ, Taphoorn MJB. Armstrong TS, et al. Lancet Oncol. 2020 Feb;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X. Lancet Oncol. 2020. PMID: 32007210 Review.
Glioma patient-reported outcome assessment in clinical care.
Tuleasca C, Knisely J, Leroy HA, Hottinger AF, Peciu-Florianu I, Levivier M, Reyns N. Tuleasca C, et al. Lancet Oncol. 2020 May;21(5):e230. doi: 10.1016/S1470-2045(20)30141-8. Lancet Oncol. 2020. PMID: 32359495 No abstract available.